Laboratory Division, Indian Council of Medical Research - National Institute of Epidemiology, Chennai, India.
ICMR School of Public Health, Indian Council of Medical Research - National Institute of Epidemiology, Chennai, India.
Clin Infect Dis. 2023 Jul 5;77(Suppl 1):S111-S117. doi: 10.1093/cid/ciad220.
Antimicrobial resistance poses a significant threat to public health globally. We studied the prevalence of colonization with extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE), carbapenem-resistant Enterobacterales (CRE), and colistin-resistant Enterobacterales (Col-RE) in hospitals and the surrounding community in South India.
Adults from 2 hospitals and the catchment community who consented to provide stool specimens were enrolled. Stools were plated on CHROMagar selective for ESCrE, CRE, and Col-RE. Bacterial identification and antibiotic susceptibility testing were done using Vitek 2 Compact and disc diffusion testing. Colistin broth microdilution was performed for a subset of isolates. Prevalence estimates were calculated with 95% confidence intervals (CIs), and differences were compared across populations using the Pearson χ 2 or Fisher exact test.
Between November 2020 and March 2022, 757 adults in the community and 556 hospitalized adults were enrolled. ESCrE colonization prevalence was 71.5% (95% CI, 68.1%-74.6%) in the community and 81.8% (95% CI, 78.4%-84.8%) in the hospital, whereas CRE colonization prevalence was 15.1% (95% CI, 12.7%-17.8%) in the community and 22.7% (95% CI, 19.4%-26.3%) in the hospital. Col-RE colonization prevalence was estimated to be 1.1% (95% CI, .5%-2.1%) in the community and 0.5% (95% CI, .2%-1.6%) in the hospital. ESCrE and CRE colonization in hospital participants was significantly higher compared with community participants (P < .001 for both).
High levels of colonization with antibiotic-resistant Enterobacterales were found in both community and hospital settings. This study highlights the importance of surveillance of colonization in these settings for understanding the burden of antimicrobial resistance.
抗菌药物耐药性对全球公共卫生构成重大威胁。我们研究了在印度南部的医院和周边社区中,广泛耐药肠杆菌科(ESCrE)、耐碳青霉烯肠杆菌科(CRE)和多黏菌素耐药肠杆菌科(Col-RE)定植的流行情况。
征得同意并提供粪便标本的 2 家医院和社区中的成年人被纳入研究。将粪便接种在选择性用于 ESCrE、CRE 和 Col-RE 的 CHROMagar 平板上。使用 Vitek 2 Compact 和纸片扩散试验进行细菌鉴定和抗生素药敏试验。对部分分离株进行多黏菌素肉汤微量稀释。使用 95%置信区间(CI)计算流行率估计值,并使用 Pearson χ 2 或 Fisher 确切检验比较不同人群之间的差异。
2020 年 11 月至 2022 年 3 月,社区中纳入 757 名成年人,住院患者中纳入 556 名成年人。社区中 ESCrE 定植率为 71.5%(95%CI,68.1%-74.6%),医院中为 81.8%(95%CI,78.4%-84.8%);社区中 CRE 定植率为 15.1%(95%CI,12.7%-17.8%),医院中为 22.7%(95%CI,19.4%-26.3%)。社区中估计 Col-RE 定植率为 1.1%(95%CI,.5%-2.1%),医院中为 0.5%(95%CI,.2%-1.6%)。医院参与者中 ESCrE 和 CRE 定植率明显高于社区参与者(均 P <.001)。
在社区和医院环境中均发现了具有高水平抗生素耐药性的肠杆菌科定植。本研究强调了在这些环境中进行定植监测以了解抗菌药物耐药负担的重要性。